Arabic Arabic English English French French German German
dark

MEI Pharma Appoints Tina C. Beamon, J.D., as Chief Compliance Officer

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the appointment of Tina C. Beamon, J.D., as chief compliance officer, effective immediately Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Viewpoint Molecular Targeting(R) Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program

Next Post

Sobi to present data at the ISTH 2021 within rare haematology diseases

Related Posts
Total
0
Share